|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C12P 21/08 | (2006.01) |
| C07H 21/00 | (2006.01) |
| (11) | Number of the document | 3339445 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17209717.2 |
| Date of filing the European patent application | 2007-09-07 | |
| (97) | Date of publication of the European application | 2018-06-27 |
| (45) | Date of publication and mention of the grant of the patent | 2020-07-15 |
| (46) | Date of publication of the claims translation | 2020-10-26 |
| (30) | Number | Date | Country code |
| 843249 P | 2006-09-08 | US |
| (72) |
WU, Chengbin, US
DIXON, Richard, W., US
BELK, Jonathan, P., US
YING, Hua, US
ARGIRIADI, Maria, A., US
CUFF, Carolyn, A., US
HINTON, Paul, R., US
KUMAR, Shankar, US
MELIM, Terry, L., US
CHEN, Yan, US
|
| (73) |
AbbVie Manufacturing Management Unlimited Company ,
70 Sir John Rogerson's Quay, Dublin 2,
IE
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Baltymai, suryšantys interleukiną 13 |
| INTERLEUKIN -13 BINDING PROTEINS |
| Payment date | Validity (years) | Amount | |
| 2025-08-25 | 19 | 347.00 EUR |
| 2026-09-07 |